MetaCap

Fortrea Cash Flow Statement

NASDAQ: FTREHealth CareMedical SpecialitiesUSD

20.84+0.47 (+2.31%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Fortrea free cash flow

In fiscal 2025, Fortrea generated $113.5 million of operating cash flow and spent $25.2 million on capital expenditures. That left free cash flow of $88.3 million, a free-cash-flow margin of 3.2% of revenue. Free cash flow was down 62.8% from the prior year's $237.3 million.

Summary generated from market data by MetaCap's automated system. Methodology

Fortrea cash flow statement (annual)

Fortrea annual cash flow statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31
Net Income-986.20M-328.50M-25.20M186.20M98.00M
Net Income growth (YoY)——-113.53%+90.00%—
Depreciation & Amortization78.00M86.90M98.00M93.60M166.30M
Stock-Based Compensation74.40M58.40M42.70M25.40M27.50M
Change in Working Capital43.80M74.10M75.90M-139.80M60.40M
Operating Cash Flow113.50M262.80M168.40M82.70M169.80M
Capital Expenditures-25.20M-25.50M-40.30M-54.40M-26.50M
Investing Cash Flow14.40M251.60M-31.80M-54.00M-26.20M
Debt Issued00570.00M00
Debt Repaid-75.70M-482.70M-15.40M00
Financing Cash Flow-76.30M-497.80M-140.80M-6.30M-128.50M
Net Change in Cash56.10M9.90M-1.80M15.80M14.30M
Free Cash Flow88.30M237.30M128.10M28.30M143.30M

This table shows 5 annual periods of Fortrea's cash flow statement, from FY 2025 back to FY 2021, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow FTRE's reporting calendar. What is a cash flow statement?

More financial data